D.A. Davidson & Co. »

Arcutis Biotherapeutics shares owned by D.A. Davidson & Co.

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by D.A. Davidson & Co. from 13F filings

Historical chart of D.A. Davidson & Co. investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by D.A. Davidson & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by D.A. Davidson & Co.

Quarter filed Position value Share count Share price at filing
2025-12-31 $835k 29k 29.04

More positions owned by D.A. Davidson & Co.

Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus 2000 Val Etf (IWN)
Spdr Series Trust State Street Spd (SPIB)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Ishares Tr Rus 2000 Grw Etf (IWO)
Ishares Tr Rus 1000 Grw Etf (IWF)
Raytheon Technologies Corp (RTX)

View all positions for D.A. Davidson & Co.

Top funds holding Arcutis Biotherapeutics

Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Rubric Capital Management
Vanguard Group
Jennison Associates
Polar Capital Holdings
State Street Corporation
Gilder, Gagnon, Howe & Co
UBS Group
Geode Capital Management
Henderson Group
D. E. Shaw & Co
Ensign Peak Advisors
Franklin Resources

View all funds holding Arcutis Biotherapeutics